Current studies have shown that STAT activation can be detected in all ovarian cancers, especially STAT3, which is associated with tumor occurrence, invasion and metastasis, suggesting that JAK/STAT signaling pathway can support ovarian cancer cell survival by inhibiting or inducing genes involved in cell survival and apoptosis. This evidence concerns the gene STAT3 and ovarian carcinoma.